Paper Report for: Oh_2022_Int.J.Biol.Macromol_217_910
Reference
Title: Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B Oh JM, Kang Y, Hwang JH, Park JH, Shin WH, Mun SK, Lee JU, Yee ST, Kim H Ref: Int J Biol Macromol, 217:910, 2022 : PubMed
Cholinesterase (ChE) and monoamine oxidase (MAO) inhibitors are being used and developed to treat Alzheimer's disease (AD), a major type of dementia patients. Fifteen 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives were synthesized and evaluated for their inhibitory activities against acetylcholinesterase (AChE), butyrylcholinesterase (BChE), monoamine oxidase-A (MAO-A), and B (MAO-B). Compound 896 was the most potent BChE inhibitor (IC(50) = 0.13 microM) with the selectivity index (SI) value of >769.23 for BChE over AChE. Compound 897 was the most potent selective MAO-B inhibitor (IC(50) = 0.73 microM; SI = 20.45 for MAO-B over MAO-A). The meta-CF(3) substituent of 896 increased BChE inhibitory activity and the para-CF(3) substituent of 897 increased MAO-B inhibitory activity. Compound 896 was a reversible noncompetitive BChE inhibitor (K(i) = 0.171 microM) and 897 was a reversible competitive MAO-B inhibitor (K(i) = 0.237 microM). Compound 896 had a lower binding energy (-13.75 kcal/mol) to BChE than 897 (-11.29 kcal/mol), and 897 had a lower binding energy to MAO-B (-11.31 kcal/mol) than that to MAO-A (-6.72 kcal/mol). Little cytotoxicity was observed for 896 and 897 to normal cells (MDCK) and human neuroblastoma cells (SH-SY5Y). This study suggested that 896 and 897 are therapeutic candidates for various neurodegenerative disorders such as AD.
        
Related information
Citations formats
Oh JM, Kang Y, Hwang JH, Park JH, Shin WH, Mun SK, Lee JU, Yee ST, Kim H (2022) Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B Int J Biol Macromol217: 910-921
Oh JM, Kang Y, Hwang JH, Park JH, Shin WH, Mun SK, Lee JU, Yee ST, Kim H (2022) Int J Biol Macromol217: 910-921